People · Operator
Named in public records as an officer, director or promoter · active 2019–2022 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ObjectiveHealth, Inc. | — | Other Health Care | Series C | $68.0M | $321.2M | 2019 |
| EvidenceCare, Inc. | — | Other Health Care | Series B | $28.0M | $50.8M | 2020 |
Donald Lazas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Lazas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Austin Poole | 1 | 5 |
| Christopher Booker | 1 | 5 |
| David Fox | 1 | 4 |
| Navid Farzad | 1 | 4 |
| Curt Futch | 1 | 3 |
| Dave Vreeland | 1 | 3 |
| Gerry Andrady | 1 | 3 |
| James Porter | 1 | 2 |
| William Sheahan | 1 | 2 |
| Van Johnson | 1 | 2 |
| Melinda Hancock | 1 | 2 |
| Stu Warren | 1 | 1 |
| Colleen Hoke | 1 | 1 |
| Duncan Reek | 1 | 1 |
| Bill Taaffe | 1 | 1 |
| Samuel Bartholomew | 1 | 1 |
| Bo Wilkes | 1 | 1 |
| Brian Fengler | 1 | 1 |
| Cyril Philip | 1 | 1 |
| David Vreeland | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.